Second-Line Bedaquiline-Based Regimens Demonstrates Microbiological Response in Patients With TB
March 4th 2024The regimen, which was used as second-line treatment in patients with drug-resistant TB, had a similar microbiological response to those with drug-sensitive TB taking first-line regimens.
Read More
AAO-HNSF Publishes Clinical Practice Guidelines for Allergen Immunotherapy
March 4th 2024AAO-HNSF guideline development group included 17 panel members, including experts from otolaryngology and allergy, those who have knowledge in clinical practice guideline development, and patient representatives.
Read More